LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

Kodu・Aktsiate loetelu・Blueprint Medicines Corp

Blueprint Medicines Corp

Suletud

Sektor Tervishoid

85.98 -3.62

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

85.4

Max

89.14

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+41.14 upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	30. okt 2024

Uudiste sentiment

By Acuity

25%

75%

52 / 366 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

85.67 / 88.98 Toetus ja vastupanu

Blueprint Medicines Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

17. okt 2024, 23:57 UTC

Kuumad aktsiad

Stocks to Watch: Netflix, MGP Ingredients, Bausch Health

17. okt 2024, 22:35 UTC

Omandamised, ülevõtmised, äriostud

SLB to Sell Interest in Palliser Block in Canada

17. okt 2024, 21:33 UTC

Tulu

Suurimad hinnamuutused turgudel

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Revenue Beat

17. okt 2024, 20:56 UTC

Tulu

Intuitive Surgical Posts 3Q Revenue Growth

17. okt 2024, 23:51 UTC

Market Talk

BHP Unlikely to Quickly Approach Anglo American Again, Says Bull -- Market Talk

17. okt 2024, 23:22 UTC

Peamised uudised

Amex Earnings Will Test Stock's Rally. Revenue Is the Focus. -- Barrons.com

17. okt 2024, 23:14 UTC

Peamised uudised

Tulu

Netflix Subscriber Growth Slows Amid Revenue Gains -- 4th Update

17. okt 2024, 22:56 UTC

Market Talk

Santos's Balance Sheet Risks to Ease From Here -- Market Talk

17. okt 2024, 22:52 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Santos's Upcoming Investor Day Likely Positive -- Market Talk

17. okt 2024, 22:32 UTC

Market Talk

De Grey Runs Into Delay on Hemi Permitting, But Approval Likely -- Market Talk

17. okt 2024, 22:23 UTC

Market Talk

Nike Outlook Revised on Unclear Outcome of Turnaround Strategy -- Market Talk

17. okt 2024, 22:13 UTC

Market Talk

Tulu

Global Equities Roundup: Market Talk

17. okt 2024, 22:13 UTC

Market Talk

Tulu

Netflix Isn't Interested in Bundling With Other Streaming Services -- Market Talk

17. okt 2024, 21:57 UTC

Peamised uudised

Tulu

Netflix Subscriber Growth Slows Amid Revenue Gains -- 3rd Update

17. okt 2024, 21:48 UTC

Omandamised, ülevõtmised, äriostud

SLB: Palliser Block Consists of Oil and Gas Wells, Surface Facilities, a Pipeline Network and Certain Oil and Gas Development Rights >SLB

17. okt 2024, 21:48 UTC

Omandamised, ülevõtmised, äriostud

SLB: Transaction Is Expected to Close Late in the 4Q >SLB

17. okt 2024, 21:48 UTC

Omandamised, ülevõtmised, äriostud

SLB: Announces Definitive Agreement to Sell Its Interests in Palliser Block

17. okt 2024, 21:32 UTC

Market Talk

Tulu

Netflix's Release Schedule Should be 'Largely Back to Normal' in 2025 -- Market Talk

17. okt 2024, 21:25 UTC

Peamised uudised

Google Executive Overseeing Search and Advertising Leaves Role -- 2nd Update

17. okt 2024, 21:21 UTC

Market Talk

Tulu

Netflix Says It Will Double Revenue from Advertising in FY25 -- Market Talk

17. okt 2024, 21:18 UTC

Tulu

Suurimad hinnamuutused turgudel

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Rev Beat

17. okt 2024, 21:10 UTC

Peamised uudised

Tulu

Lucid Stock Tumbles 18%. EV Maker Plans Huge Share Sale, Sees Wider Losses. -- Barrons.com

17. okt 2024, 21:03 UTC

Omandamised, ülevõtmised, äriostud

CSX, Canadian Pacific Kansas City, Genesee & Wyoming: Surface Transportation Board Approves CSX, CPKC Respective Applications Regarding Acquisition of Rail Lines Operated by G&W's Meridian & Bigbee Railroad

17. okt 2024, 20:55 UTC

Tulu

Netflix Clobbers Third-Quarter Estimates, Guides Above Views -- IBD

17. okt 2024, 20:55 UTC

Tulu

Netflix Stock Jumps on a Strong Outlook for Profit Margin. Prices Are Going Up Across the World. -- Barrons.com

17. okt 2024, 20:50 UTC

Tulu

Netflix Stock Jumps on a Strong Outlook for Profit Margin. Prices Are Growing Up Across the World. -- Barrons.com

17. okt 2024, 20:50 UTC

Market Talk

Tulu

Auto & Transport Roundup: Market Talk

17. okt 2024, 20:50 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Tech, Media & Telecom Roundup: Market Talk

17. okt 2024, 20:50 UTC

Market Talk

Tulu

Basic Materials Roundup: Market Talk

17. okt 2024, 20:49 UTC

Peamised uudised

Tulu

Netflix Subscriber Growth Slows Amid Revenue Gains -- 2nd Update

Võrdlus sarnastega

Hinnamuutus

Blueprint Medicines Corp Prognoos

Hinnasiht

By TipRanks

41.14% tõus

12 kuu keskmine prognoos

Keskmine 126.08 USD 41.14%

Kõrge 155 USD

Madal 97 USD

Põhineb 14 Wall Streeti analüütiku instrumendi Blueprint Medicines Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

14 ratings

Osta

Hoia

Müü

Põhineb 14 analüütiku instrumendi Blueprint Medicines Corp aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

85.67 / 88.98Toetus ja vastupanu

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

52 / 366 Pingereas Tervishoid

Finantsandmed

Muud aktsiad sektorist

LLY

Eli Lilly and Co.

916.07

↓-0.02%

UNH

UnitedHealth Group Inc

566.13

↓-0.87%

NVO

Novo Nordisk A-S

118.17

↑ +0.23%

JNJ

Johnson and Johnson

164.55

↑ +0.16%

ABBV

AbbVie Inc

188.57

↓-1%

Blueprint Medicines Corp

Ülevaade

Aktsiahinna muutus

Soovitused

Dividendid

Uudiste sentiment

Tehniline skoor

Blueprint Medicines Corp Graafik

Seotud uudised

Võrdlus sarnastega

Blueprint Medicines Corp Prognoos

Hinnasiht

Hinnangu Konsensus

Tehniline skoor

Sentiment

Finantsandmed

Muud aktsiad sektorist

Crucial information about Facebook accounts